blood group typing market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
RESEARCH REPORT<br />
MARCH - 2018<br />
GLOBAL BLOOD GROUP TYPING MARKET<br />
BY PRODUCT TYPE, SIZE, SHARE, GROWTH, TRENDS AND FORECASTS 2017-2022
Global Rubella Vaccine Market<br />
The global Blood Group Typing <strong>market</strong> is anticipated to grow at 9.80% CAGR from 2017<br />
to 2022 and it is estimated that the global <strong>market</strong> was valued at USD 2.15 billion in 2017<br />
and is expected to reach USD 3.43 billion by 2022.<br />
Classification of <strong>blood</strong> on the basis of absence and presence of antibodies or inherited<br />
antigenic substances on the surface of red <strong>blood</strong> cells is termed as <strong>blood</strong> <strong>group</strong> <strong>typing</strong>.<br />
These antigens may be proteins, carbohydrates, glycoproteins, or glycolipids, depending<br />
on the <strong>blood</strong> <strong>group</strong> system. Some of these antigens are present on the surface of other<br />
types of cells of various tissues. Several of these red <strong>blood</strong> cell surface antigens can<br />
stem from one allele and collectively form a <strong>blood</strong> <strong>group</strong> system.<br />
The global <strong>market</strong> for molecular <strong>blood</strong> <strong>group</strong>ing is increasing significantly. The <strong>market</strong><br />
has a lot of potential due to a growth in the demand for <strong>blood</strong> transfusion. For the<br />
purpose of transfusion, donor <strong>blood</strong> compatibility with recipient patient is highly<br />
important. Therefore, before transfusion of <strong>blood</strong>, in order to check compatibility, <strong>blood</strong><br />
samples are cross-matched with each other. Transfusion of <strong>blood</strong> is usually safe;<br />
however, alloimmunization can create a complication in the recipient. The<br />
alloimmunization can be dreadful in patients’ suffering from diseases like sickle cell<br />
anemia. The molecular <strong>blood</strong> <strong>group</strong> <strong>typing</strong> is used to determine the presence of antigens<br />
in the red <strong>blood</strong> cells through testing. In general, A, B, and D (Rh) antigens are tested as<br />
part of standard procedure, followed by determination of other antigens if required.<br />
Reverse <strong>group</strong>ing confirms ABO <strong>blood</strong> <strong>group</strong> <strong>typing</strong> by detecting expected isoagglutinins.<br />
The varying use of <strong>blood</strong> <strong>typing</strong> and <strong>group</strong>ing test in research activities and<br />
transfusion procedures has upsurge the molecular <strong>blood</strong> <strong>typing</strong>, <strong>group</strong>ing and infectious<br />
disease nucleic acid testing <strong>market</strong>. Factors such as the increased government<br />
interventions and growing demand have increased the <strong>market</strong> for molecular <strong>blood</strong><br />
<strong>typing</strong>, <strong>group</strong>ing, and infectious disease NAT. However, restraining factors like<br />
administrative and logistical challenges, slow turnaround, high cost, the requirement of<br />
high-end equipment and inadequate information systems for handling the results. Owing<br />
to these facts, the <strong>market</strong> observes a rise in the demand for molecular <strong>typing</strong> tests. The<br />
adoption of molecular testing in <strong>blood</strong> transfusion procedures has mitigated the<br />
challenges faced to a significant extent.<br />
The global Blood Group Typing Market is segmented on the basis of Technique,<br />
Product, Test Type, and End User. On the basis of Product, the <strong>market</strong> is segmented<br />
into Consumable, Instrument, and Service. Consumables segment is further segmented<br />
into anti-human globulin reagents, red <strong>blood</strong> cells reagents, antisera reagents, and <strong>blood</strong><br />
bank saline. Consumables segment is expected to grow at the highest CAGR during the<br />
forecast period. The sudden rise in <strong>blood</strong> donation rates is another key factor driving the<br />
growth of this segment. On the basis of Test Type, the <strong>market</strong> is segmented into<br />
prestige ABO, Antigen, Antibody Screening, Cross Matching, and HLA. The antibody<br />
screening segment is projected to witness the highest CAGR in this <strong>market</strong> segment in<br />
the coming years due to the increasing prevalence of chronic disorders and growing<br />
demand for the early diagnosis of diseases. On the basis of Technique, the <strong>market</strong> is<br />
segmented into Assay, PCR, Microarray, and Massively Parallel Sequencing. The PCRbased<br />
and microarray techniques segment accounted for the largest share of this <strong>market</strong><br />
segment and is further expected to grow at the highest CAGR during the forecast period<br />
due to the rising prevalence of chronic diseases and increasing R&D activities focused<br />
on understanding the molecular basis of <strong>blood</strong> and antibody-antigen interactions. On the<br />
basis of End User, the <strong>market</strong> is segmented into Clinical Laboratories, Blood Banks,<br />
Hospitals, and Other End Users. The hospitals end-user segment is expected to grow at<br />
the highest CAGR during the forecast period owing to an increase in the awareness<br />
+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com
Global Rubella Vaccine Market<br />
among people regarding <strong>blood</strong> donations and its importance, rising number of <strong>blood</strong><br />
donations, and growing requirement of <strong>blood</strong> in surgical treatments.<br />
On the basis of geography, the Blood Group Typing <strong>market</strong> is segmented into North<br />
America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America<br />
occupies the largest <strong>market</strong> share followed by Europe. The United States has been the<br />
major <strong>market</strong> across the world. Factors such as advanced technology, research, and<br />
development activities have boosted the North America <strong>market</strong>. Asia Pacific is expected<br />
to witness the highest CAGR during the forecast period due to the rising population, and<br />
an increase in disposable income. Furthermore, due to these factors, the Asian <strong>market</strong> is<br />
observing a high number of new entrants compared to those in developed regions.<br />
The <strong>market</strong> is dominated by companies like Bio-Rad Laboratories, Inc., Grifols, S.A.,<br />
Immucor Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, BAG<br />
Healthcare GmbH, Rapid Labs, Day medical SA, DIAGAST, and AXO Science.<br />
.TABLE OF CONTENT<br />
1. Introduction<br />
1.1 Market Definition<br />
1.2 Study Deliverables<br />
1.3 Base Currency, Base Year and Forecast Periods<br />
1.4 General Study Assumptions<br />
2. Research Methodology<br />
3. Overview<br />
2.1 Introduction<br />
2.2 Research Phases<br />
2.2.1 Secondary Research<br />
2.2.2 Primary Research<br />
2.2.3 Econometric Modelling<br />
2.2.4 Expert Validation<br />
2.3 Analysis Design<br />
2.4 Study Timeline<br />
3.1 Executive Summary<br />
3.2 Key Inferences<br />
3.3 Epidemology<br />
4. Drivers, Restraints, Opportunities, and Challenges Analysis<br />
(DROC)<br />
4.1 Market Drivers<br />
4.2 Market Restraints<br />
+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com
Global Rubella Vaccine Market<br />
4.3 Key Challenges<br />
4.4 Current Opportunities in the Market<br />
5. Market Segmentation<br />
5.1 Product<br />
5.2 Test Type<br />
5.1.1 Introduction<br />
5.1.2 Consumables<br />
5.1.3 Instrument<br />
5.1.4 Services<br />
5.1.2.1 Antisera Reagents<br />
5.1.2.2 Red Blood Cell Reagents<br />
5.1.2.3 Anti-Human Globulin Reagents<br />
5.1.2.4 Blood Bank Saline<br />
5.1.5 Y-o-Y Growth Analysis, By Product<br />
5.1.6 Market Attractiveness Analysis, By Product<br />
5.1.7 Market Share Analysis, By Product<br />
5.2.1 Introduction<br />
5.2.2 ABO<br />
5.2.3 Antigen<br />
5.2.4 Antibody Screening<br />
5.2.5 Cross Matching<br />
5.2.6 HLA<br />
5.2.7 Y-o-Y Growth Analysis, By Test Type<br />
5.2.8 Market Attractiveness Analysis, By Test Type<br />
5.2.9 Market Share Analysis, By Test Type<br />
Browse full report @ https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>-reports/<strong>blood</strong>-<strong>group</strong><strong>typing</strong>-<strong>market</strong>-6350/<br />
5.3 Technique<br />
5.3.1 Introduction<br />
5.3.2 Assay<br />
5.3.3 PCR<br />
5.3.4 Microarray<br />
5.3.5 Massively Parallel Sequencing<br />
+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com
Global Rubella Vaccine Market<br />
5.3.6 Y-o-Y Growth Analysis, By Technique<br />
5.3.7 Market Attractiveness Analysis, By Technique<br />
5.3.8 Market Share Analysis, By Technique<br />
Request sample report @ https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>-reports/<strong>blood</strong><strong>group</strong>-<strong>typing</strong>-<strong>market</strong>-6350/request-sample<br />
5.4 End User<br />
5.4.1 Introduction<br />
5.4.2 Hospitals<br />
5.4.3 Clinical Laboratories<br />
5.4.4 Blood Banks<br />
5.4.5 Other End Users<br />
5.4.6 Y-o-Y Growth Analysis, By End User<br />
5.4.7 Market Attractiveness Analysis, By End User<br />
5.4.8 Market Share Analysis, By End User<br />
Inquire before buying @ https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>-reports/<strong>blood</strong><strong>group</strong>-<strong>typing</strong>-<strong>market</strong>-6350/inquire<br />
6. Geographical Analysis<br />
6.1 Introduction<br />
6.1.1 Regional Trends<br />
6.1.2 Impact Analysis<br />
6.1.3 Y-o-Y Growth Analysis<br />
6.1.3.1 By Geographical Area<br />
6.1.3.2 By Product<br />
6.1.3.3 By Test Type<br />
6.1.3.4 By Technique<br />
6.1.3.5 By End User<br />
Request discount @ https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>-reports/<strong>blood</strong>-<strong>group</strong><strong>typing</strong>-<strong>market</strong>-6350/request-discount<br />
6.1.4 Market Attractiveness Analysis<br />
6.1.4.1 By Geographical Area<br />
6.1.4.2 By Product<br />
6.1.4.3 By Test Type<br />
6.1.4.4 By Technique<br />
6.1.4.5 By End User<br />
+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com
Global Rubella Vaccine Market<br />
6.2 North America<br />
6.1.5 Market Share Analysis<br />
6.1.1 Introduction<br />
6.1.5.1 By Geographical Area<br />
6.1.5.2 By Product<br />
6.1.2 United States<br />
6.1.3 Canada<br />
6.1.5.3 By Test Type<br />
6.1.5.4 By Technique<br />
6.1.5.5 By End User<br />
Buy full report @ https://www.<strong>market</strong>dataforecast.com/cart/buy-now/<strong>blood</strong>-<strong>group</strong>-<strong>typing</strong><strong>market</strong>-6350<br />
6.3 Europe<br />
6.2.1 Introduction<br />
6.2.2 U.K<br />
6.2.3 Spain<br />
6.2.4 Germany<br />
6.2.5 Italy<br />
6.4 Asia-Pacific<br />
6.2.6 France<br />
6.3.1 Introduction<br />
6.3.2 China<br />
6.3.3 India<br />
6.3.4 Japan<br />
6.3.5 Australia<br />
6.5 Latin America<br />
6.3.6 South Korea<br />
6.4.1 Introduction<br />
6.4.2 Brazil<br />
6.4.3 Argentina<br />
6.4.4 Mexico<br />
6.4.5 Rest of Latin America<br />
6.6 Middle East & Africa<br />
+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com
Global Rubella Vaccine Market<br />
6.5.1 Introduction<br />
6.5.2 Middle-East<br />
6.5.3 Africa<br />
7. Strategic Analysis<br />
7.1 PESTLE analysis<br />
7.1.1 Political<br />
7.1.2 Economic<br />
7.1.3 Social<br />
7.1.4 Technological<br />
7.1.5 Legal<br />
7.1.6 Environmental<br />
7.2 Porter’s Five analysis<br />
7.2.1 Bargaining Power of Suppliers<br />
7.2.2 Bargaining Power of Consumers<br />
7.2.3 Threat of New Entrants<br />
7.2.4 Threat of Substitute Products and Services<br />
7.2.5 Competitive Rivalry within the Industry<br />
8. Market Leaders' Analysis<br />
8.1 Bio-Rad Laboratories Inc.<br />
8.1.1 Overview<br />
8.1.2 Product Analysis<br />
8.1.3 Financial analysis<br />
8.1.4 Recent Developments<br />
8.1.5 SWOT analysis<br />
8.1.6 Analyst View<br />
8.2 Grifols S.A.<br />
8.3 Immucor Inc.<br />
8.4 Ortho Clinical Diagnostics Inc.<br />
8.5 Quotient Ltd.<br />
8.6 Novacyt Group<br />
8.7 BAG Healthcare GmbH<br />
8.8 Rapid Labs<br />
8.9 Day medical SA<br />
+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com
Global Rubella Vaccine Market<br />
8.10 DIAGAST<br />
9. Competitive Landscape<br />
9.1 Market share analysis<br />
9.2 Merger and Acquisition Analysis<br />
9.3 Agreements, collaborations and Joint Ventures<br />
9.4 New Product Launches<br />
10. Market Outlook and Investment Opportunities<br />
Appendix<br />
a) List of Tables<br />
b) List of Figures<br />
Check out other related reports in Healthcare<br />
Blood <strong>group</strong> <strong>typing</strong> Market : https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>-reports/<strong>blood</strong>-<strong>group</strong><strong>typing</strong>-<strong>market</strong>-6350/<br />
North america <strong>blood</strong> <strong>group</strong> <strong>typing</strong> Market : https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>reports/<strong>blood</strong>-<strong>group</strong>-<strong>typing</strong>-<strong>market</strong>-6352/<br />
Europe <strong>blood</strong> <strong>group</strong> <strong>typing</strong> Market: https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>-reports/europe<strong>blood</strong>-<strong>group</strong>-<strong>typing</strong>-<strong>market</strong>-6354/<br />
Asia-Pacific <strong>blood</strong> <strong>group</strong> <strong>typing</strong> Market: https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>reports/asia-pacific-<strong>blood</strong>-<strong>group</strong>-<strong>typing</strong>-<strong>market</strong>-6356/<br />
+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com
Global Rubella Vaccine Market<br />
SCOPE OF THE REPORT<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Regional and country-level analysis and forecasts of the study <strong>market</strong>; providing<br />
Insights on the major countries/regions in which this industry is blooming and to also<br />
identify the regions that are still untapped<br />
Segment-level analysis in terms of technology, component, and type along with<br />
<strong>market</strong> size forecasts and estimations to detect key areas of industry growth in detail<br />
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the<br />
<strong>market</strong> and their impact on shifting <strong>market</strong> dynamics<br />
Study of the effect of exogenous and endogenous factors that affect the global<br />
<strong>market</strong>; which includes broadly demographic, economics, and political, among other<br />
macro-environmental factors presented in an extensive PESTLE Analysis<br />
Study the micro environment factors that determine the overall profitability of an<br />
Industry, using Porter’s five forces analysis for analyzing the level of competition<br />
and business strategy development<br />
A comprehensive list of key <strong>market</strong> players along with their product portfolio,<br />
current strategic interests, key financial information, legal issues, SWOT analysis and<br />
analyst overview to study and sustain the <strong>market</strong> environment<br />
Competitive landscape analysis listing out the mergers, acquisitions, collaborations<br />
in the field along with new product launches, comparative financial studies and<br />
recent developments in the <strong>market</strong> by the major companies<br />
An executive summary, abridging the entire report in such a way that decisionmaking<br />
personnel can rapidly become acquainted with background information,<br />
concise analysis and main conclusions<br />
Expertly devised analyst overview along with Investment opportunities to provide<br />
both individuals and organizations a strong financial foothold in the markeExpertly<br />
devised analyst overview along with Investment opportunities to provide both<br />
individuals and organizations a strong financial foothold in the <strong>market</strong><br />
+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com
ABOUT US<br />
Market Data Forecast is a firm working in the areas of <strong>market</strong><br />
research and business intelligence. We have rich experience in<br />
research across various business domains and we cater to the needs<br />
of both individual and corporate clients. Our research services assist<br />
clients in key business areas like business process improvement, key<br />
decision making and developing appropriate corporate strategy. We<br />
are truly committed to our clients and other stakeholders for<br />
providing customized research services of the highest quality.<br />
CONTACT INFORMATION<br />
We always look forward to working with new clients, pushing our<br />
boundaries and extending our reach beyond global horizons. Get in<br />
touch with us for further queries.<br />
Website: www.<strong>market</strong>dataforecast.com<br />
E-Mail: contact@<strong>market</strong>dataforecast.com<br />
Phone: +1 888-702-9626 (U.S Toll free),<br />
+91 7680952236 (Indian Office).<br />
FOR MORE INFORMATION<br />
+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com